Belgian clinic records breast cancer breakthrough
21 October 2005, BRUSSELS – Brussels' prestigious cancer clinic Institut Bordet has played a key role in developing a medicine which could revolutionise the treatment of breast cancer.
21 October 2005
BRUSSELS – Brussels' prestigious cancer clinic Institut Bordet has played a key role in developing a medicine which could revolutionise the treatment of breast cancer.
Bordet's doctor Martine Picard has led the European testing of an antibody which is showing excellent results in patient trials. The New England Journal of Medicine, which published the results on Friday, said the medicine Stratus will completely transform the therapeutic approach to cases of breast cancer.
It has also been tested in the US and in Asia through the study organised by Brest International Group.
A total of 3,200 women have taken the medicine, with around 2,000 to be treated with it in the next year.
The drug is an antibody which has been shown to halve the risk of tumours spreading to other organs, making it the biggest therapeutic breakthrough in the last 20 years, according to Bordet.
The researchers also say the medicine does not cause the side-effects of chemotherapy, such as hair loss and nausea.
It does cause some cardio-vascular side-effects, but the experts believe these are reversible and are minor health risks compared to the benefit of the treatment.
[Copyright Expatica News 2005]
Subject: Belgian news